Our results further confirmed that anti-CCP2 and anti-CCP3 tests have higher sensitivity for the diagnosis of rheumatic diseases, such as RA or JIA, than the anti-CCP1 test. This evidence concerns the gene AGBL3 and rheumatic disorder.